Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network.
Chaix ML, Desquilbet L, Descamps D, Costagliola D, Deveau C, Galimand J, Goujard C, Signori-Schmuck A, Schneider V, Tamalet C, Pellegrin I, Wirden M, Masquelier B, Brun-Vezinet F, Rouzioux C, Meyer L; French PRIMO Cohort Study Group (ANRS CO 06); French ANRS AC11 Resistance Study Group. Chaix ML, et al. Among authors: pellegrin i. Antivir Ther. 2007;12(8):1305-10. Antivir Ther. 2007. PMID: 18240870
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.
Surial B, Ramírez Mena A, Roumet M, Limacher A, Smit C, Leleux O, Mocroft A, van der Valk M, Bonnet F, Peters L, Rockstroh JK, Günthard HF, Berzigotti A, Rauch A, Wandeler G; Swiss HIV Cohort Study; ATHENA Observational Cohort Study; EuroSIDA; ANRS CO3 Aquitaine Cohort. Surial B, et al. J Hepatol. 2023 May;78(5):947-957. doi: 10.1016/j.jhep.2022.12.029. Epub 2023 Jan 21. J Hepatol. 2023. PMID: 36690280 Free article.
Primary infection with zidovudine-resistant HIV.
Masquelier B, Lemoigne E, Pellegrin I, Douard D, Sandler B, Fleury HJ. Masquelier B, et al. Among authors: pellegrin i. N Engl J Med. 1993 Oct 7;329(15):1123-4. N Engl J Med. 1993. PMID: 8371739 No abstract available.
Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads.
Pellegrin I, Legrand E, Neau D, Bonot P, Masquelier B, Pellegrin JL, Ragnaud JM, Bernard N, Fleury HJ. Pellegrin I, et al. Among authors: pellegrin jl. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Apr 15;11(5):438-47. doi: 10.1097/00042560-199604150-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8605588
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment.
Burgard M, Izopet J, Dumon B, Tamalet C, Descamps D, Ruffault A, Vabret A, Bargues G, Mouroux M, Pellegrin I, Ivanoff S, Guisthau O, Calvez V, Seigneurin JM, Rouzioux C. Burgard M, et al. Among authors: pellegrin i. AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1939-47. doi: 10.1089/088922200750054666. AIDS Res Hum Retroviruses. 2000. PMID: 11153076
Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy.
Ngo-Giang-Huong N, Deveau C, Da Silva I, Pellegrin I, Venet A, Harzic M, Sinet M, Delfraissy JF, Meyer L, Goujard C, Rouzioux C; Frnech PRIMO Cohort Study Group. Ngo-Giang-Huong N, et al. Among authors: pellegrin i. AIDS. 2001 Apr 13;15(6):665-73. doi: 10.1097/00002030-200104130-00001. AIDS. 2001. PMID: 11371680
134 results